The GeneTex SARS-CoV-2 (COVID-19) Spike-ACE2 Binding / Neutralization Assay Kit is an in vitro assay for qualitative SARS-CoV-2 neutralization reagent screening. The kit includes the recombinant RBD proteins of the wildtype (WT) strain and five major WHO-designated variants of concern (i.e., Alpha, Beta, Gamma, Delta, and Kappa) for strain-specific neutralization analysis.
The suitable sample types include but not limit to purified antibodies and serum. The suggested sample loading amount is 50μl per well. Please see the protocol for detailed procedure.
Rabbit monoclonal antibody against the SARS-CoV-2 RBD protein with strong neutralization capability (lyophilized)
Rabbit monoclonal antibody against the SARS-CoV-2 RBD protein with non-neutralizing capability (lyophilized)
The entire kit can be stored at 2-8ºC for up to 6 months.
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
SARS-CoV-2 Neutralization kit , COVID19 Neutralization kit , COVID-19 Neutralization kit , SARS2 Neutralization kit
GTX536401 Neutralizing/Inhibition Image
Inhibition analysis of SARS-CoV-2 (COVID-19) spike neutralizing control antibody using SARS-CoV-2 (COVID-19) Spike-ACE2 Binding / Neutralization Assay Kit (GTX536401).
The recovery of SARS-CoV-2 (COVID-19) Spike-ACE2 Binding / Neutralization Assay Kit (GTX536401) was determined by spiking a spike neutralizing control antibody in human serum.